6,12-Di-O-methyl-2'',4''''-bis-O-(trimethylsilyl)-erythromycin 9-[2-(Triphenylmethyl)hydrazone] Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

6,12-Di-O-methyl-2'',4''''-bis-O-(trimethylsilyl)-erythromycin 9-[2-(Triphenylmethyl)hydrazone]is an intermediate in the synthesis of 12-O-Methyl Clarithromycin which is a methylated impurity of the semi-synthetic macrolide antibiotic Clarithromycin (C559750). 12-O-Methyl Clarithromycin was shown to inhibit uptake of Clarithromycin into the lung cells.

6,12-Di-O-methyl-2'',4''''-bis-O-(trimethylsilyl)-erythromycin 9-[2-(Triphenylmethyl)hydrazone] Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

6,12-Di-O-methyl-2'',4''''-bis-O-(trimethylsilyl)-erythromycin 9-[2-(Triphenylmethyl)hydrazone] Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
BOC Sciences	16314854226	inquiry@bocsci.com	United States	9713	58

---

• 6,12-Di-O-methyl-2'',4''''-bis-O-(trimethylsilyl)-erythromycin 9-[2-(Triphenylmethyl)hydrazone]
• C64H103N3O12Si2